Drawing for LOOK FOR LAL D!

USPTO serial 86346188

LOOK FOR LAL D!

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FATHY, DOMINIC
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LOOK FOR LAL D!?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth A. Walker

ELIZABETH A. WALKER CHOATE, HALL & STEWART LLP2 INTERNATIONAL PL STE 3200BOSTON, MA 02110-4120UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceuticals and pharmaceutical preparations for rare, terminal and genetic diseases; pharmaceuticals and pharmaceutical preparations for dyslipidemia, hepatic steatosis, liver disease, adrenal enlargement, adrenal calcification, growth retardation, and hepatic fibrosis; pharmaceuticals and pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceuticals and pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceuticals and pharmaceutical preparations for the treatment of Liposomal Acid Lipase deficiencyACTIVE—
016printed matter, namely books, newsletters, brochures, booklets, journal articles, academic publications, case studies, posters, educational course materials and handouts, reference guides, and teaching materials in the field of Lysosomal Acid Lipase deficiencyINACTIVE - INSUFFICIENT FEE RECEIVED—
041education services, namely, conducting classes, conferences, lectures, seminars, workshops, and continuing medical education courses, in person, via the internet, or via webinar, in the field of medicine and healthcare; education services, namely conducting classes, conferences, lectures, seminars, workshops, and continuing medical education courses and workshops for medical professionals, in person, via the internet, or via webinar, in the field of Lysosomal Acid Lipase deficiency; electronic publications, namely books, newsletters, brochures, booklets, journal articles, academic publications, case studies, posters, educational course materials and handouts, reference guides, and teaching materials in the field of Lysosomal Acid Lipase deficiencyINACTIVE - INSUFFICIENT FEE RECEIVED—
044promoting public awareness of Lysosomal Acid Lipase deficiency; providing information on Lysosomal Acid Lipase deficiency, research, prevention, treatments, and patient care services; providing information on rare, terminal and genetic diseases research, prevention, treatments, and patient care services; providing a web site featuring information on Lysosomal Acid Lipase deficiency, research, prevention, treatments, and patient care services; providing a web site featuring information on rare, terminal and genetic diseases research, prevention, treatments, and patient care services; providing a website featuring information regarding events promoting public awareness of Lysosomal Acid Lipase deficiency; providing information regarding medical treatment of diseases; providing information regarding medical treatment of Lysosomal Acid Lipase deficiency; providing support services for patients and families of patients with Lysosomal Acid Lipase Deficiency, namely, companionship, help with medical forms, help with insurance claims and forms, emotional counseling and emotional supportINACTIVE - INSUFFICIENT FEE RECEIVED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 1, 2015MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 30, 2015ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 9, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 3, 2014DOCKASSIGNED TO EXAMINER—
Jul 31, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 28, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 28, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 26, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance